Nonetheless, with ACCC approval, we raise our fair value estimate for no-moat Sigma by 99% to AUD 1.55 per share with the ...

The return of Donald Trump to the US presidency brings the prospect of more US tax cuts and deregulation, but also more ...

Exhibit 2 reveals that presidential party affiliation accounts for less than 1% of the variability in returns across ...

Article Page URL has been copied to clipboard for sharing. This article was provided by a third-party and the opinions expressed here are the author’s. Morningstar values diversity of thought and ...

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver ...

Heimstaden AB is engaged in owning, developing, and managing residential properties. The company's geographical segments include Sweden, Czechia, Iceland, United Kingdom, Finland, Poland, Denmark, ...

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include ...

Carlton Investments Ltd is engaged in the long-term holding of shares and units in entities listed on the Australian Securities Exchange. Revenue for the company is generated in the form of dividends ...

Nidec is a global leader of brushless DC motors. Brushless DC motors have advantages over other types of motors in power efficiency, silence, and durability. Nidec possesses the number-one market ...

Global Ship Lease Inc operates in the container shipping industry. The company owns and charters out containerships under long-term, fixed-rate charters to container liner companies. The majority of ...

Heico is an aerospace and defense supplier that focuses on creating niche replacement parts for commercial aircraft and components for defense products. In commercial aerospace, Heico is the largest ...

Dimerix Ltd is a biopharmaceutical company developing new therapies in areas with unmet medical needs. The company is developing four product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney ...